PETALING JAYA, May 20 – Malaysian Genomics Resource Centre Berhad (“MGRC” or “the Group”) has announced a groundbreaking collaboration between its subsidiary MGRC Therapeutics Sdn Bhd (“MGRCT”) and Twistcode Technologies Sdn Bhd (“Twistcode Technologies”). This partnership aims to revolutionize bioinformatics services through the development of the Bioinformatics Enhanced-Accelerated Services Terminal (B.E.A.S.T), a cutting-edge platform set to redefine genomics research and biopharmaceutical advancements across Malaysia and the Middle East.
The Memorandum of Understanding (MoU) between MGRCT and Twistcode Technologies outlines a strategic alliance to drive research, development, and commercialization efforts in the field of bioinformatics. By integrating artificial intelligence and supercomputing capabilities, the collaboration seeks to streamline bioinformatics processes, offering a comprehensive solution to meet the evolving needs of the healthcare industry. Azri Azerai, Executive Chairman of Malaysian Genomics, expressed excitement about the partnership, emphasizing its potential to elevate genomics and biopharmaceutical capabilities to unprecedented heights.
